Results 171 to 180 of about 3,790 (190)
Some of the next articles are maybe not open access.

Intravenous labetalol in the emergency treatment of hypertension.

Journal of clinical hypertension, 1986
Labetalol is a unique alpha- and beta-adrenergic-receptor blocking agent that has recently been approved for the treatment of hypertensive emergencies and urgencies. This agent lowers peripheral vascular resistance by vasodilatation with little or no effect on cardiac output.
openaire   +1 more source

Labetalol by continuous intravenous infusion in severe hypertension.

Journal of clinical hypertension, 1986
This study documents our experience with labetalol administered by continuous intravenous infusion for severe hypertension. Infusions were performed in 14 hospitalized patients (15 infusions) with supine diastolic pressure greater than 125 mmHg or supine systolic pressure greater than 200 mmHg.
J T, Wright   +3 more
openaire   +1 more source

INTRAVENOUS LABETALOL FOR TREATMENT OF POSTOPERATIVE HYPERTENSION

Anesthesiology, 1988
F. Le Bret   +6 more
openaire   +1 more source

The Response of Plasma Catecholamines to Intravenous Labetalol

Survey of Anesthesiology, 1985
M. -S. LIN   +4 more
openaire   +1 more source

Intravenous labetalol is available in Australia.

Anaesthesia and intensive care, 2010
A, Dennis   +3 more
openaire   +1 more source

Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta‐analysis

BJOG: an International Journal of Obstetrics and Gynaecology, 2016
Richard Kirubakaran, Shashank Shekhar
exaly  

901: THE SAFETY OF HIGH-DOSE INTRAVENOUS LABETALOL

Critical Care Medicine, 2018
Jason Hecht   +2 more
openaire   +1 more source

Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial

BJOG: an International Journal of Obstetrics and Gynaecology, 2012
Peng Chiong Tan, S Z Omar
exaly  

Home - About - Disclaimer - Privacy